Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stasi

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Tropical Animal Health and Production|October 27, 2005
Biochemical and haematological measurements in beef cattle in Mendoza plain rangelands (Argentina)E G Grünwaldt, J C Guevara, O R Estévez, et al.
Blood|December 15, 1994
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpuraR Stasi, E Stipa, M Masi, et al.
Leukemia|February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative GroupA M Carella, P Carlier, E Pungolino, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaR Stasi, G Del Poeta, M Masi, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
Cancer Genetics and Cytogenetics|March 1, 1995
Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (M0)M C Cox-Froncillo, M Zollino, G Del Poeta, et al.
Annals of Hematology|February 1, 1993
All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemiasA Venditti, R Stasi, M Masi, et al.
Leukemia|August 1, 1995
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemiaM D Simone, R Stasi, A Venditti, et al.
Cancer|June 15, 1996
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factorsR Stasi, A Venditti, G Del Poeta, et al.
Leukemia & Lymphoma|March 1, 1995
CD7 expression in acute myeloid leukemiaG Del Poeta, R Stasi, A Venditti, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Tropical Animal Health and Production|October 27, 2005
Biochemical and haematological measurements in beef cattle in Mendoza plain rangelands (Argentina)E G Grünwaldt, J C Guevara, O R Estévez, et al.
Blood|December 15, 1994
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpuraR Stasi, E Stipa, M Masi, et al.
Leukemia|February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative GroupA M Carella, P Carlier, E Pungolino, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaR Stasi, G Del Poeta, M Masi, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
Cancer Genetics and Cytogenetics|March 1, 1995
Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (M0)M C Cox-Froncillo, M Zollino, G Del Poeta, et al.
Annals of Hematology|February 1, 1993
All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemiasA Venditti, R Stasi, M Masi, et al.
Leukemia|August 1, 1995
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemiaM D Simone, R Stasi, A Venditti, et al.
Cancer|June 15, 1996
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factorsR Stasi, A Venditti, G Del Poeta, et al.
Leukemia & Lymphoma|March 1, 1995
CD7 expression in acute myeloid leukemiaG Del Poeta, R Stasi, A Venditti, et al.
Pageof 8